Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
CC transcript
|
|
BIOMIMETIC THERAPEUTICS, INC. (BMTI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/10/2014 |
SC 13G/A
| AQR CAPITAL MANAGEMENT LLC reports a 0% stake in BioMimetic Therapeutics, Inc. |
| 03/18/2013 |
4/A
| WATSON DOUGLAS G (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.|
Txns:
| Disposed/sold 8,840 options to buy
@ $11.64, valued at
$102.9k
Disposed/sold 10,653 options to buy
@ $9.95, valued at
$106k
Disposed/sold 8,538 options to buy
@ $12.66, valued at
$108.1k
|
|
| 03/18/2013 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 03/18/2013 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 03/13/2013 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/11/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/11/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/11/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/11/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/11/2013 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 03/06/2013 |
4
| Novo A/S (10% Owner) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.|
Txns:
| Disposed/sold 4,720,065 shares
@ $0 |
|
| 03/06/2013 |
4
| Christensen Thorkil K. (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.|
Txns:
| Disposed/sold 2,507 shares
@ $0 |
|
| 03/06/2013 |
8-K
| Quarterly results |
| 03/05/2013 |
4
| Friedlaender Gary E (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 11,977 shares
@ $9.07, valued at
$108.6k
Paid exercise price by delivering 5,797 shares
@ $9.07, valued at
$52.6k
Disposed/sold 64,957 shares
@ $0
Disposed/sold 14,894 shares
@ $0
Disposed/sold 11,762 shares
@ $0
Disposed/sold 4,258 shares
@ $0
Disposed/sold 3,377 shares
@ $0
Exercised 18,736 options to buy
@ $5.8, valued at
$108.7k
Exercised 20,000 options to buy
@ $2.63, valued at
$52.6k
Disposed/sold 5,831 options to buy
@ $17.09, valued at
$99.7k
Disposed/sold 8,840 options to buy
@ $11.64, valued at
$102.9k
|
|
| 03/05/2013 |
4
| FEDERICO CHARLES (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 11,977 shares
@ $9.0738, valued at
$108.7k
Disposed/sold 27,834 shares
@ $0
Exercised 18,736 options to buy
@ $5.8, valued at
$108.7k
Exercised 20,000 options to buy
@ $2.63, valued at
$52.6k
Disposed/sold 18,096 options to buy
@ $17.09, valued at
$309.3k
Disposed/sold 8,840 options to buy
@ $11.64, valued at
$102.9k
Disposed/sold 10,653 options to buy
@ $9.95, valued at
$106k
Disposed/sold 8,538 options to buy
@ $12.66, valued at
$108.1k
|
|
| 03/05/2013 |
4
| Pagano Russell P. (VP, Reg. & Clinical Affairs) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 32,305 shares
@ $9.0738, valued at
$293.1k
Disposed/sold 44,411 shares
@ $0
Exercised 70,000 options to buy
@ $2.08, valued at
$145.6k
Disposed/sold 10,000 options to buy
@ $14.41, valued at
$144.1k
Disposed/sold 35,000 options to buy
@ $13.45, valued at
$470.8k
Disposed/sold 35,000 options to buy
@ $8.54, valued at
$298.9k
Disposed/sold 35,000 options to buy
@ $11.97, valued at
$419k
Disposed/sold 25,000 options to buy
@ $9.7, valued at
$242.5k
|
|
| 03/05/2013 |
4
| MURPHY JAMES G (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.|
Txns:
| Disposed/sold 56,964 shares
@ $0
Exercised 18,736 options to buy
@ $5.8, valued at
$108.7k
Exercised 20,000 options to buy
@ $2.63, valued at
$52.6k
Disposed/sold 5,831 options to buy
@ $17.09, valued at
$99.7k
Disposed/sold 8,840 options to buy
@ $11.64, valued at
$102.9k
Disposed/sold 10,653 options to buy
@ $9.95, valued at
$106k
Disposed/sold 8,538 options to buy
@ $12.66, valued at
$108.1k
|
|
| 03/05/2013 |
4
| WATSON DOUGLAS G (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.|
Txns:
| Disposed/sold 96,021 shares
@ $0
Exercised 18,736 options to buy
@ $5.8, valued at
$108.7k
Exercised 20,000 options to buy
@ $2.63, valued at
$52.6k
Disposed/sold 5,831 options to buy
@ $17.09, valued at
$99.7k
Disposed/sold 8,840 options to buy
@ $11.64, valued at
$102.9k
Disposed/sold 10,653 options to buy
@ $9.95, valued at
$106k
Disposed/sold 8,538 options to buy
@ $12.66, valued at
$108.1k
|
|
| 03/05/2013 |
4
| PAPASAN LARRY W (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.|
Txns:
| Disposed/sold 69,517 shares
@ $0
Exercised 18,376 options to buy
@ $5.8, valued at
$106.6k
Exercised 20,000 options to buy
@ $2.63, valued at
$52.6k
Disposed/sold 5,831 options to buy
@ $17.09, valued at
$99.7k
Disposed/sold 8,840 options to buy
@ $11.64, valued at
$102.9k
Disposed/sold 10,653 options to buy
@ $9.95, valued at
$106k
Disposed/sold 8,538 options to buy
@ $12.66, valued at
$108.1k
|
|
| 03/05/2013 |
4
| BULLOCK LAWRENCE E (CFO) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.|
Txns:
| Disposed/sold 89,151 shares
@ $0
Disposed/sold 21,000 shares
@ $0
Disposed/sold 112,500 options to buy
@ $2.87, valued at
$322.9k
Disposed/sold 27,000 options to buy
@ $12.59, valued at
$339.9k
Disposed/sold 25,000 options to buy
@ $14.41, valued at
$360.3k
Disposed/sold 30,000 options to buy
@ $8.54, valued at
$256.2k
Disposed/sold 37,500 options to buy
@ $11.97, valued at
$448.9k
Disposed/sold 40,000 options to buy
@ $13.45, valued at
$538k
Disposed/sold 80,000 options to buy
@ $2.08, valued at
$166.4k
|
|
| 03/05/2013 |
4
| Lynch Samuel Eugene (President and CEO) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 77,623 shares
@ $9.0738, valued at
$704.3k
Disposed/sold 1,392,923 shares
@ $0
Disposed/sold 5,550 shares
@ $0
Exercised 51,000 options to buy
@ $3.47, valued at
$177k
Exercised 170,000 options to buy
@ $2.08, valued at
$353.6k
Disposed/sold 45,000 options to buy
@ $14.41, valued at
$648.5k
Disposed/sold 205,703 options to buy
@ $13.88, valued at
$2.9M
Disposed/sold 85,000 options to buy
@ $13.45, valued at
$1.1M
Disposed/sold 80,000 options to buy
@ $12.59, valued at
$1M
Disposed/sold 80,000 options to buy
@ $8.54, valued at
$683.2k
Disposed/sold 75,000 options to buy
@ $11.97, valued at
$897.8k
|
|
| 03/05/2013 |
4
| Ehrlich Christopher B (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.|
Txns:
| Disposed/sold 1,250 shares
@ $0
Disposed/sold 941,177 shares
@ $0
Disposed/sold 857,692 shares
@ $0
Disposed/sold 6,846 shares
@ $0
Disposed/sold 24,538 shares
@ $0
Disposed/sold 5,831 options to buy
@ $17.09, valued at
$99.7k
Disposed/sold 8,840 options to buy
@ $11.64, valued at
$102.9k
|
|
| 03/01/2013 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 02/26/2013 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 02/12/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 02/12/2013 |
8-K
| Other Events |
| 01/24/2013 |
4
| Pagano Russell P. (VP, Reg. & Clinical Affairs) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.|
Txns:
| Sold 1,381 shares
@ $8.101, valued at
$11.2k
|
|
| 01/23/2013 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition |
| 01/14/2013 |
8-K
| Other Events |
| 01/08/2013 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 01/07/2013 |
8-K
| Other Events |
| 01/03/2013 |
8-K
| Other Events, Financial Statements and Exhibits |
| 01/03/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 12/21/2012 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
|
|